DENDREON
Seattle-based biotechnology company focused on targeting cancer to transform lives through the discovery, development and commercialization of novel therapeutics to fight cancer. Dendreon applies its expertise in antigen identification, engineering and cell processing to produce Active Cellular Immunotherapy (ACI) product candidates designed to stimulate an immune response. ACI holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity. In addition to ACI product candidates, the company is also developing an orally-available small molecule targeting TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia.
DENDREON
Social Links:
Industry:
Biotechnology Life Science Therapeutics
Founded:
1992-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.dendreon.com
Total Employee:
1001+
Status:
Active
Contact:
(877) 256-4545
Technology used in webpage:
SPF SSL By Default Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Domain Not Resolving Apache Global Site Tag Nginx
Current Advisors List
Current Employees Featured
Founder
Stock Details
Company's stock symbol is NASDAQ:DNDN
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2003-07-30 | Corvas International, Inc. | Corvas International, Inc. acquired by Dendreon | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-08-23 | Dendreon Pharmaceuticals Appoints Sherry Saurini as Vice President of Quality |
Official Site Inspections
http://www.dendreon.com
- Host name: 254.88.215.35.bc.googleusercontent.com
- IP address: 35.215.88.254
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
Loading ... 